Use of biological and chemical molecules in regulating embryo implantation and endometrial receptivity

IF 0.7 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Reproductive and Developmental Medicine Pub Date : 2022-07-13 DOI:10.1097/RD9.0000000000000027
Xian Chen, Shuya Sun, E. Ng, R. Li, W. Yeung, Kai-Fai Lee
{"title":"Use of biological and chemical molecules in regulating embryo implantation and endometrial receptivity","authors":"Xian Chen, Shuya Sun, E. Ng, R. Li, W. Yeung, Kai-Fai Lee","doi":"10.1097/RD9.0000000000000027","DOIUrl":null,"url":null,"abstract":"This review summarizes the drugs and chemicals that may modulate embryo implantation. Non-hormonal molecules, including aspirin, improved endometrial blood flow, while low molecular weight heparin, vitamin E, sildenafil, and atosiban modulated the expression of endometrial genes. Hormonal factors, including human chorionic gonadotropin and growth hormones, can regulate the expression of endometrial receptivity markers. Other immunomodulatory molecules, including granulocyte colony-stimulating factor, peripheral blood mononuclear cells, autologous platelet-rich plasma, and intralipid and intravenous immunoglobulins, may improve implantation rate by modulating endometrial immune functions. Medicinal extracts of the Chinese herbs Paeonia lactiflora and Perilla frutescens increased the expression of leukemia inhibitory factors in endometrial epithelial cells. Recently, the use of the commercially available Library of Pharmacologically Active Compounds with a high-throughput screening method has provided an approach to screen for compounds that may potentially enhance or suppress embryo implantation. Whether these biomedical findings translate into clinical effects that enhance or suppress embryo implantation requires further investigation.","PeriodicalId":20959,"journal":{"name":"Reproductive and Developmental Medicine","volume":"6 1","pages":"234 - 242"},"PeriodicalIF":0.7000,"publicationDate":"2022-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive and Developmental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/RD9.0000000000000027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This review summarizes the drugs and chemicals that may modulate embryo implantation. Non-hormonal molecules, including aspirin, improved endometrial blood flow, while low molecular weight heparin, vitamin E, sildenafil, and atosiban modulated the expression of endometrial genes. Hormonal factors, including human chorionic gonadotropin and growth hormones, can regulate the expression of endometrial receptivity markers. Other immunomodulatory molecules, including granulocyte colony-stimulating factor, peripheral blood mononuclear cells, autologous platelet-rich plasma, and intralipid and intravenous immunoglobulins, may improve implantation rate by modulating endometrial immune functions. Medicinal extracts of the Chinese herbs Paeonia lactiflora and Perilla frutescens increased the expression of leukemia inhibitory factors in endometrial epithelial cells. Recently, the use of the commercially available Library of Pharmacologically Active Compounds with a high-throughput screening method has provided an approach to screen for compounds that may potentially enhance or suppress embryo implantation. Whether these biomedical findings translate into clinical effects that enhance or suppress embryo implantation requires further investigation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用生物和化学分子调控胚胎着床和子宫内膜容受性
本文就可能调控胚胎着床的药物和化学物质作一综述。非激素分子,包括阿司匹林,改善子宫内膜血流量,而低分子量肝素,维生素E,西地那非和阿托西班调节子宫内膜基因的表达。激素因素,包括人绒毛膜促性腺激素和生长激素,可以调节子宫内膜容受性标志物的表达。其他免疫调节分子,包括粒细胞集落刺激因子、外周血单核细胞、自体富血小板血浆、脂质和静脉注射免疫球蛋白,可能通过调节子宫内膜免疫功能来提高着床率。芍药和紫苏提取物可提高子宫内膜上皮细胞白血病抑制因子的表达。最近,利用市售的药理学活性化合物库和高通量筛选方法,为筛选可能增强或抑制胚胎着床的化合物提供了一种方法。这些生物医学发现是否转化为促进或抑制胚胎植入的临床效应还需要进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Reproductive and Developmental Medicine
Reproductive and Developmental Medicine OBSTETRICS & GYNECOLOGY-
CiteScore
1.60
自引率
12.50%
发文量
384
审稿时长
23 weeks
期刊最新文献
Exogenous estrogen partially rescues progesterone deficiency and autophagosome enlargement in Mcoln1 -/- mouse model with lysosomal storage disorder. Study of the influence of the biochemical composition of the human native ejaculate on the preservation of the male gametes’ activity after the application of cryopreservation technology Impact of Microbiota on Female Fertility and Gynecological problems Machine learning-based prediction of pregnancy outcomes in couples with non-obstructive azoospermia using micro-TESE for ICSI: a retrospective cohort study Text mining and data analysis identifies potential drugs and pathways for polycystic ovary syndrome treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1